Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM) clinical-lymphoma-myeloma-leukemia.com/article/S2152-… #mmsm #btsm
Muzaffar Qazilbash
Verified account This account is verified. Learn more@Transplant_Doc
Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own
265 Following 7.7K Followers 20K Posts
Latest posts 5
Impact of EMD on outcomes in RRMM treated with talquetamab: U.S. Myeloma Immunotherapy Consortium
- Similar response rates (>60%) but shorter PFS compared to patients without EMD nature.com/articles/s4140… #mmsm #bmtsm @AimazAfrough @ldandersonjr
- Similar response rates (>60%) but shorter PFS compared to patients without EMD nature.com/articles/s4140… #mmsm #bmtsm @AimazAfrough @ldandersonjr
To the scientific world, Moderna’s cancer vaccine’s results proved that a highly personalized, immune-targeting medication can work.
To investors, it didn’t work well enough. wsj.com/health/pharma/… via @WSJ
To investors, it didn’t work well enough. wsj.com/health/pharma/… via @WSJ
Could AI help scientists with their paperwork?
-Examinations of papers in “predatory journals”, where authors pay for publication, find around 90% are AI-generated economist.com/science-and-te…
-Examinations of papers in “predatory journals”, where authors pay for publication, find around 90% are AI-generated economist.com/science-and-te…
AI companies want to become frontier scientific researchers
-Sakana AI, a Tokyo-based research group, unveiled an “AI scientist” which its creators claimed could complete all the tasks required to write a scientific paper economist.com/science-and-te…
-Sakana AI, a Tokyo-based research group, unveiled an “AI scientist” which its creators claimed could complete all the tasks required to write a scientific paper economist.com/science-and-te…